Facebook
Twitter
LinkedIn
ForwardStem Cell Transplant Course Spring 2023
This two-day course addresses the individual and joint needs of nursing, pharmacy, and other professions in relation to Stem Cell Transplantation. It includes information on current transplantation issues such as patient work-up, disease process, patient care, and management. Selected topics include differentiating types of transplants, mobilization and preparative regimens, growth factors, the role of total body irradiation, transfusion issues, graft versus host disease, CAR T-Cell therapies, and other transplant related topics.
Target Audience
Oncology nurses, pharmacists, advanced practice providers, social workers, and other healthcare professionals working with patients undergoing Stem Cell Transplant.
Learning Objectives
The learner will be able to:
- Discuss the role of stem cell transplant in cancer and other diseases.
- Compare and contrast the role of autologous, allogeneic, haploidentical, and cord blood transplant in treating hematological malignancies.
- Understand preparative regimen chemotherapy and what preparative regimen is indicated based on disease and other comorbidities.
- Understand the transfusion needs surrounding patients who need or receive a stem cell transplant.
- Describe appropriate interventions for the management of transplant associated complications including acute and chronic graft verse host disease, infection, and organ toxicities.
- Describe the process of pre transplant evaluation, mobilization, cell collection, cell infusion, and troubleshooting infusion related complications for transplant patients and donors.
- Understand HLA typing and donor selection for allogeneic and haploidentical transplants.
- Understand the purpose and importance of immunosuppression in the stem cell transplant population.
- Identify the role of rehabilitation resources in patients undergoing stem cell transplant.
- Understand the short term and long term follow up requirements and role of survivorship care planning, including patient education across the transplant continuum of care.
- Recall the clinical background of chimeric antigen receptor modified T-cells and the diseases indicated for this type of treatment.
- Discuss the outpatient management of a stem cell transplant patient.
- Recall the nursing care considerations of a patient receiving CAR T-cell therapy.
Melissa Bastacky, PharmD, BCOP | Megan Beer, PA-C | Abbigail Bollinger, PA-C
|
Ashur-Dee Brown, MSN, RN, BMTCN | Courtney Dube, PT, DPT | Sawa Ito, MD, PhD |
Shannon Joy, CRNP | Janet Loper, BSN, RN | Wendy Lucas, MSN, RN, CCRN, CCNS, BMTCN |
Megan Marmol, BSN, RN | Jennifer Minnier, PA-C | Melissa Potter, MSW, LCSW, OSW-C |
Brittni Prosdocimo, MSN, RN, BMTCN | Alison Sehgal, MD, MS | Cheryl Tompkins MSN, CRNP, BMTCN |
Darrell Triulzi, MD | Jackie Wojton, BSN, RN, OCN |
|
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 13 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
The maximum number of hours awarded for this Continuing Nursing Education activity is 13 contact hours.
To receive 13 Contact Hours, the learner must sign in, attend the entire activity, and complete the activity evaluation.
Available Credit
- 13.00 AAPA Category I CME
- 13.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 13.00 Attendance